Neriifolin, another CTS, was used as a model of Parkinson’s disease, because it decreases dopaminergic neuron survival through NKA inhibition, which increases the concentration of intracellular Na+, reactive oxygen species (ROS), and p53 activation (101). Here, TAC1 is linked to Parkinson disease.